| Nov 21 |
Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024?
|
| Nov 15 |
Genmab A/S (GMAB): Among 12 High Growth Large Cap Stocks to Buy Now
|
| Nov 9 |
Genmab A/S (GMAB) Q3 2024 Earnings Conference Call Transcript
|
| Nov 9 |
Genmab A/S 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 8 |
High Growth Tech Stocks To Watch In November 2024
|
| Nov 7 |
Genmab AS (GMAB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Pipeline ...
|
| Nov 6 |
Genmab Announces Financial Results for the First Nine Months of 2024
|
| Nov 6 |
Genmab: Looking To Manage My Position Around Q3 Earnings
|
| Nov 5 |
Genmab to Present at Jefferies London Healthcare Conference
|
| Nov 5 |
Genmab to Showcase Strength and Breadth of Comprehensive Epcoritamab-bysp Development Program at 2024 American Society of Hematology (ASH) Annual Meeting
|
